Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2007

Open Access 01-12-2007 | Research article

A new approach of nonparametric estimation of incidence and lifetime risk based on birth rates and incident events

Authors: Henrik Støvring, Mei-Cheng Wang

Published in: BMC Medical Research Methodology | Issue 1/2007

Login to get access

Abstract

Background

Incidence and lifetime risk of diabetes are important public health measures. Traditionally, nonparametric estimates are obtained from survey data by means of a Nelson-Aalen estimator which requires data information on both incident events and risk sets from the entire cohort. Such data information is rarely available in real studies.

Methods

We compare two different approaches for obtaining nonparametric estimates of age-specific incidence and lifetime risk with emphasis on required assumptions. The first and novel approach only considers incident cases occurring within a fixed time window–we have termed this cohort-of-cases data–which is linked explicitly to the birth process in the past. The second approach is the usual Nelson-Aalen estimate which requires knowledge on observed time at risk for the entire cohort and their incident events. Both approaches are used on data on anti-diabetic medications obtained from Odense Pharmacoepidemiological Database, which covers a population of approximately 470,000 over the period 1993–2003. For both methods we investigate if and how incidence rates can be projected.

Results

Both the new and standard method yield similar sigmoidal shaped estimates of the cumulative distribution function of age-specific incidence. The Nelson-Aalen estimator gives somewhat higher estimates of lifetime risk (15.65% (15.14%; 16.16%) for females, and 17.91% (17.38%; 18.44%) for males) than the estimate based on cohort-of-cases data (13.77% (13.74%; 13.81%) for females, 15.61% (15.58%; 15.65%) for males). Accordingly the projected incidence rates are higher based on the Nelson-Aalen estimate–also too high when compared to observed rates. In contrast, the cohort-of-cases approach gives projections that fit observed rates better.

Conclusion

The developed methodology for analysis of cohort-of-cases data has potential to become a cost-effective alternative to a traditional survey based study of incidence. To allow more general use of the methodology, more research is needed on how to relax stationarity assumptions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mokdad A, Bowman B, Ford E, Vinicor F, Marks J, Koplan J: The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001, 286: 1195-200. 10.1001/jama.286.10.1195.CrossRefPubMed Mokdad A, Bowman B, Ford E, Vinicor F, Marks J, Koplan J: The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001, 286: 1195-200. 10.1001/jama.286.10.1195.CrossRefPubMed
2.
go back to reference Honeycutt AA, Boyle JP, Broglio KR, Thompson TJ, Hoerger TJ, Geiss LS, Narayan KMV: A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050. Health Care Manag Sci. 2003, 6 (3): 155-164. 10.1023/A:1024467522972.CrossRefPubMed Honeycutt AA, Boyle JP, Broglio KR, Thompson TJ, Hoerger TJ, Geiss LS, Narayan KMV: A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050. Health Care Manag Sci. 2003, 6 (3): 155-164. 10.1023/A:1024467522972.CrossRefPubMed
3.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27 (5): 1047-53. 10.2337/diacare.27.5.1047.CrossRefPubMed Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27 (5): 1047-53. 10.2337/diacare.27.5.1047.CrossRefPubMed
4.
go back to reference Støvring H, Andersen M, Beck-Nielsen H, Green A, Vach W: Counting drugs to understand the disease: The case ofmeasuring the diabetes epidemic. Popul Health Metr. 2007, 5: 2-10.1186/1478-7954-5-2.CrossRefPubMedPubMedCentral Støvring H, Andersen M, Beck-Nielsen H, Green A, Vach W: Counting drugs to understand the disease: The case ofmeasuring the diabetes epidemic. Popul Health Metr. 2007, 5: 2-10.1186/1478-7954-5-2.CrossRefPubMedPubMedCentral
5.
go back to reference Narayan KMV, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ: Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care. 2006, 29 (9): 2114-2116. 10.2337/dc06-1136.CrossRefPubMed Narayan KMV, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ: Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care. 2006, 29 (9): 2114-2116. 10.2337/dc06-1136.CrossRefPubMed
6.
go back to reference Evans JMM, Barnett KN, Ogston SA, Morris AD: Increasing prevalence of type 2 diabetes in a Scottish population: effect of increasing incidence or decreasing mortality?. Diabetologia. 2007, 50 (4): 729-732. 10.1007/s00125-006-0585-9.CrossRefPubMed Evans JMM, Barnett KN, Ogston SA, Morris AD: Increasing prevalence of type 2 diabetes in a Scottish population: effect of increasing incidence or decreasing mortality?. Diabetologia. 2007, 50 (4): 729-732. 10.1007/s00125-006-0585-9.CrossRefPubMed
7.
go back to reference Fox CS, Pencina MJ, Meigs JB, Vasan RS, Levitzky YS, D'Agostino RB: Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation. 2006, 113 (25): 2914-2918. 10.1161/CIRCULATIONAHA.106.613828.CrossRefPubMed Fox CS, Pencina MJ, Meigs JB, Vasan RS, Levitzky YS, D'Agostino RB: Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation. 2006, 113 (25): 2914-2918. 10.1161/CIRCULATIONAHA.106.613828.CrossRefPubMed
8.
go back to reference Narayan KMV, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF: Lifetime risk for diabetes mellitus in the United States. JAMA. 2003, 290 (14): 1884-1890. 10.1001/jama.290.14.1884.CrossRefPubMed Narayan KMV, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF: Lifetime risk for diabetes mellitus in the United States. JAMA. 2003, 290 (14): 1884-1890. 10.1001/jama.290.14.1884.CrossRefPubMed
9.
go back to reference Harris M, Flegal K, Cowie C, Eberhardt M, Goldstein D, Little R, Wiedmeyer H, Byrd-Holt D: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care. 1998, 21 (4): 518-24. 10.2337/diacare.21.4.518.CrossRefPubMed Harris M, Flegal K, Cowie C, Eberhardt M, Goldstein D, Little R, Wiedmeyer H, Byrd-Holt D: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care. 1998, 21 (4): 518-24. 10.2337/diacare.21.4.518.CrossRefPubMed
10.
go back to reference Prentice RL: A Case-Cohort Design for Epidemiologic Cohort Studies and Disease Prevention Trials. Biometrika. 1986, 73: 1-11. 10.1093/biomet/73.1.1.CrossRef Prentice RL: A Case-Cohort Design for Epidemiologic Cohort Studies and Disease Prevention Trials. Biometrika. 1986, 73: 1-11. 10.1093/biomet/73.1.1.CrossRef
11.
go back to reference Mantel N: Synthetic retrospective studies and related topics. Biometrics. 1973, 29 (3): 479-86. 10.2307/2529171.CrossRefPubMed Mantel N: Synthetic retrospective studies and related topics. Biometrics. 1973, 29 (3): 479-86. 10.2307/2529171.CrossRefPubMed
13.
go back to reference Oakes D: Survival times: aspects of partial likelihood. Internat Statist Rev. 1981, 49 (3): 235-264. With discussion and a reply by the authorCrossRef Oakes D: Survival times: aspects of partial likelihood. Internat Statist Rev. 1981, 49 (3): 235-264. With discussion and a reply by the authorCrossRef
15.
go back to reference Lubin J, Gail M: Biased selection of controls for case-control analyses of cohort studies. Biometrics. 1984, 40: 63-75. 10.2307/2530744.CrossRefPubMed Lubin J, Gail M: Biased selection of controls for case-control analyses of cohort studies. Biometrics. 1984, 40: 63-75. 10.2307/2530744.CrossRefPubMed
16.
go back to reference The WHO Collaborating Centre for Drug Statistics Methodology: ATC index with DDDs and Guidelines for ATC classification and DDD assignment. Oslo. 2001 The WHO Collaborating Centre for Drug Statistics Methodology: ATC index with DDDs and Guidelines for ATC classification and DDD assignment. Oslo. 2001
17.
go back to reference Støvring H, Andersen M, Beck-Nielsen H, Green A, Vach W: Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database. Lancet. 2003, 362 (9383): 537-8. 10.1016/S0140-6736(03)14116-5.CrossRefPubMed Støvring H, Andersen M, Beck-Nielsen H, Green A, Vach W: Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database. Lancet. 2003, 362 (9383): 537-8. 10.1016/S0140-6736(03)14116-5.CrossRefPubMed
18.
go back to reference Turnbull BW: The empirical distribution function with arbitrarily grouped, censored and truncated data. J R Statist Soc A. 1976, 38 (3): 290-295. Turnbull BW: The empirical distribution function with arbitrarily grouped, censored and truncated data. J R Statist Soc A. 1976, 38 (3): 290-295.
19.
go back to reference Andersen PK, Borgan O, Gill RD, Keiding N: Statistical models based on counting processes. 1997, New York: Springer-Verlag, Corrected second printing Andersen PK, Borgan O, Gill RD, Keiding N: Statistical models based on counting processes. 1997, New York: Springer-Verlag, Corrected second printing
20.
go back to reference Keiding N: Independent delayed entry. Survival Analysis: State of the Art. Edited by: Klein JP, Goel PK. 1992, Kluwer Academic Publishers, 309-326.CrossRef Keiding N: Independent delayed entry. Survival Analysis: State of the Art. Edited by: Klein JP, Goel PK. 1992, Kluwer Academic Publishers, 309-326.CrossRef
21.
go back to reference Støvring H: Selection bias due to immigration in pharmacoepidemiologic studies. Pharmacoepidemiol Drug Saf. 2007, 16 (6): 681-686. 10.1002/pds.1419.CrossRefPubMed Støvring H: Selection bias due to immigration in pharmacoepidemiologic studies. Pharmacoepidemiol Drug Saf. 2007, 16 (6): 681-686. 10.1002/pds.1419.CrossRefPubMed
22.
go back to reference Keiding N: Age-specific Incidence and Prevalence: a Statistical Perspective. J R Statist Soc A. 1991, 154 (3): 371-412. 10.2307/2983150.CrossRef Keiding N: Age-specific Incidence and Prevalence: a Statistical Perspective. J R Statist Soc A. 1991, 154 (3): 371-412. 10.2307/2983150.CrossRef
23.
go back to reference Faergemann C, Lauritsen JM, Brink O, Stovring H: What is the lifetime risk of contact with an A&E Department or an Institute of Forensic Medicine following violent victimisation?. Injury. 2006, 39 (1): 121-127. 10.1016/j.injury.2006.05.004.CrossRefPubMed Faergemann C, Lauritsen JM, Brink O, Stovring H: What is the lifetime risk of contact with an A&E Department or an Institute of Forensic Medicine following violent victimisation?. Injury. 2006, 39 (1): 121-127. 10.1016/j.injury.2006.05.004.CrossRefPubMed
24.
go back to reference Narayan KMV, Boyle JP, Thompson TJ, Gregg EW, Williamson DF: Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care. 2007, 30 (6): 1562-1566. 10.2337/dc06-2544.CrossRefPubMed Narayan KMV, Boyle JP, Thompson TJ, Gregg EW, Williamson DF: Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care. 2007, 30 (6): 1562-1566. 10.2337/dc06-2544.CrossRefPubMed
25.
go back to reference Keiding N, Holst C, Green A: Retrospective estimation of diabetes incidence from information in a prevalent population and historical mortality. Am J Epidemiol. 1989, 130 (3): 588-600.PubMed Keiding N, Holst C, Green A: Retrospective estimation of diabetes incidence from information in a prevalent population and historical mortality. Am J Epidemiol. 1989, 130 (3): 588-600.PubMed
Metadata
Title
A new approach of nonparametric estimation of incidence and lifetime risk based on birth rates and incident events
Authors
Henrik Støvring
Mei-Cheng Wang
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2007
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/1471-2288-7-53

Other articles of this Issue 1/2007

BMC Medical Research Methodology 1/2007 Go to the issue